COMMUNIQUÉS West-GlobeNewswire

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions
26/06/2024
Lengthens Patent Exclusivity of Plogosertib until August 2040 BERKELEY HEIGHTS, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a [...]
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
26/06/2024
DALLAS, June 26, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic [...]
Ocean Spray and Brightseed Expand Partnership to Validate Novel Health Benefits Of Bioactive Compounds Found In Various Cranberry Varieties Using Forager® AI
26/06/2024
The companies’ latest research findings that demonstrate cranberries’ hidden health potential to be presented in a poster session at NUTRITION 2024 SAN FRANCISCO, June 26, 2024 (GLOBE NEWSWIRE) -- Brightseed , the [...]
Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal
26/06/2024
Study demonstrates strong statistical separation between patients receiving Nexalin’s DIFS® technology in combination with escitalopram (Lexapro) vs sham group receiving escitalopram alone Two-thirds of patients [...]
Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO
26/06/2024
The AlterG NEO combines updated user-friendly design with trusted Anti-Gravity technology for precise and consistent unweighting in physical rehabilitation and athletic training Updated features and a cost-effective [...]
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
26/06/2024
Study published in peer-reviewed journal finds BioStem’s products offer overall better treatment efficiency, and greater efficiency in general wound closure POMPANO BEACH, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- BioStem [...]
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
26/06/2024
AXA is the 2 nd Largest Provider of Private Medical Insurance in the UK Payer Coverage is the Most Important Catalyst Aclarion can Achieve to Drive Volume and Revenue AXA Represents the First Insurance Company to [...]
University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial
26/06/2024
Ongoing Study is Investigating RenovoGem™ to treat Locally Advanced Pancreatic Cancer LOS ALTOS, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc . (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a clinical-stage [...]
Tiny Health and Rupa Health Team Up to Transform Preventative Care
26/06/2024
AUSTIN, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- Tiny Health , the first at-home gut microbiome test for babies, and Rupa Health , the platform leader in specialty laboratory testing, have announced a partnership to [...]
Major shareholder announcement
26/06/2024
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis, that as of June 21, BlackRock, Inc. crossed the 5% threshold regarding issued share [...]
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
26/06/2024
MALVERN, Pa., June 26, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative [...]
SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
26/06/2024
Results from primary analysis of the SYMON-I pilot clinical study consistent with IL-6 as a predictor of patients who have a mortality event with 28 days after sepsis and septic shock diagnosis and are admitted to the [...]
iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024
26/06/2024
Newly Launched ProFound Cloud Delivers Radiologists Cost-Effective, Secure, and Scalable Access to iCAD’s Breast Health Suite of AI Solutions NASHUA, N.H., June 26, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a [...]
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
26/06/2024
VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the development and [...]
VYNE Therapeutics to Participate in Leerink Partners Therapeutics Forum
26/06/2024
Boston event to focus on Immunology & Inflammation (I&I) and Metabolic Diseases BRIDGEWATER, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical- [...]
HealthLynked Promotes Bill Crupi to Chief Operating Officer
26/06/2024
NAPLES, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- HealthLynked Corp. ( OTCQB: HLYK ), a pioneering provider of healthcare technology solutions, is pleased to announce the promotion of Bill Crupi to the position of Chief [...]
Konica Minolta Healthcare and Apollo Enterprise Imaging Partner to Provide Enterprise-Wide Clinical Workflows and Image-Enabled EMR
26/06/2024
WAYNE, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas announced today a strategic partnership with Apollo Enterprise Imaging Corp to offer a full enterprise-wide, multi-specialty clinical [...]
Oruka Therapeutics Announces Key Additions to Leadership Team and Board of Directors
26/06/2024
Paul Quinlan joins as General Counsel Alan Lada joins as VP of Investor Relations Kristine Ball, President & CEO of Antiva Biosciences, appointed to Board of Directors MENLO PARK, Calif., and WALTHAM, Mass., June 26 [...]
ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
26/06/2024
Selected for oral presentation Conference will be held in Milan on September 21-23 MADRID and CAMBRIDGE, Mass., June 26, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage [...]

Pages